Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:07 AM UTC
| NCT Number | NCT07061288 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE1 |
| Target Enrollment | 116 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of August 28, 2026: Clinical trial NCT07061288 is currently recruiting participants. This phase1 study for schizophrenia is actively seeking new participants at 8 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07061288 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07061288 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.